Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 30, 2005, Pages 4655-4660

  Dong, Zhi Zhen ^a   Yao, Deng Fu ^a   Yao, Deng Bing ^a   Wu, Xin Hua ^a   Wu, Wei ^a   Qiu, Li Wei ^a   Jiang, Dao Rong ^a   Zhu, Jian Hua ^a   Meng, Xian Yong ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; IGF II

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; MESSENGER RNA; SOMATOMEDIN B;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER STAGING; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY ANALYSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; TUMOR VOLUME; VIRUS HEPATITIS;

EID: 23844440431     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i30.4655     Document Type: Article

References (39)

1. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-395
2. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385-392
3. Yao DF, Horie C, Horie T, Shimizu I, Meng XY, Ito S. Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze river. Tokushima J Exp Med 1994; 41: 49-56
4. Shimizu I, Yao DF, Horie C, Yasuda M, Shiba M, Horie T, Nishikado T, Meng XY, Ito S. Mutations in a hydrophilic part of the core gene of hepatitis C virus from patients with hepatocellular carcinoma in China. J Gastroenterol 1997: 32: 47-55
5. Yao DF, Jiang DR, Huang ZW, Lu JX, Tao QY, Yu ZJ, Meng XY. Abnormal expression of hepatoma specific γ-glutamyl transferase and alteration of γ-glutamyl transferase gene methylation status in patients with hepato-cellular carcinoma. Cancer 2000; 88: 761-769
6. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21: 403-407
7. Yao DF, Dong ZZ, Yang DM, Zhu YS, Jiang DR, Lu JX. Peripheral blood AFP mRNA amplification in the diagnosis and differential diagnosis of hepatocellular carcinoma. Zhonghua Putong Waike Zazhi 2000; 15: 474-477
8. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ, Park BC. Insulin-like growth factor II induced by hypoxia may contribute to angiogennesis of human hepatocellular carcinoma. Cancer Res 1998; 58: 348-351
9. Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Oncogene 2000; 19: 3717-3726
10. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-346
11. Aihara T, Noguchi S, Miyoshi Y, Nakano H, Sasaki Y, Nakamura Y, Monden M, Imaoka S. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver. Hepatology 1998; 28: 86-89
12. Fiorentino M, Grigioni WF, Baccarini P, D'Errico A, De Mitri MS, Pisi E, Mancini AM. Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immuno-histochemical study. Diagn Mol Pathol 1994; 3: 59-65
13. Scharf JG, Dombrowski F, Ramadori G. The IGF axis and hepato-carcinogenesis. Mol Pathol 2001; 54: 138-144
14. Bae MH, Lee MJ, Bae SK, Lee OH, Lee YM, Park BC, Kim KW. Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Lett 1998; 128: 41-46
15. Kang-Park S, Lee YI, Lee YI. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells. FEBS Lett 2003; 545: 203-208
16. Carmeliet P. Angiogenesis in health and disease. Nature Med 2003; 9: 653-660
17. Park BC, Huh MH, Seo JH. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. J Hepatol 1995; 22: 286-294
18. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860
19. The Liver Cancer Committee of Chinese Anticancer Association. Diagnostic criteria of primary hepatocellular carcinoma. Zhonghua Ganzangbing Zazhi 2000; 8: 135
20. The Group of Viral Hepatitis Research (2000, Xian). The Prevention and Cure Scheme of Viral Hepatitis. Zhonghua Ganzangbing Zazhi 2000; 8: 324-329
21. Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL, Varga JL. Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. Proc Natl Acad Sci USA 2003; 100: 15836-15841
22. Rall LB, Scott J, Bell GI. Human insulin-like growth factor I and II messenger RNA: isolation of complementary DNA and analysis of expression. Meth Enzymol 1987; 146: 239-248
23. Benham FJ, Povey S. Members of the human glyceraldehyde-3-phosphate dehydrogenase-related gene family map to dispersed chromosomal locations. Genomics 1989; 5: 209-214
24. Ito S, Yao DF, Nii C, Horie T, Kamamura M, Nishikada T, Honda H, Shibata H, Shimizu I, Meng XY. Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1994; 9: 245-249
25. Orito E, Mizokami M. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology 2003; 46: 408-412
26. Scharf JG, Braulke T. The role of the IGF axis in hepatocarcinogenesis. Horm Metab Res 2003; 35: 685-693
27. Zhang J, Chan EK. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma. Autoimmun Rev 2002; 1: 146-153
28. Huynh H, Chow PK, Ooi LL, Soo KC. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Differ 2002; 13: 115-122
29. Lee S, Park U, Lee YI. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 2001; 283: 167-177
30. Ng IO, Lee JM, Srivastava G, Ng M. Expression of insulin-like growth factor II mRNA in hepatocellular carcinoma. J Gastroenterol Hepatol 1998; 13: 152-157
31. Zhang N, Siegel K, Odenthal M, Becker R, Oesch F, Dienes HP, Schirmacher P, Steinberg P. The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells. Hepatology 1997; 25: 900-905
32. Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ. Expression of insulin -like growth factor II in hepatitis B, Cirrhosis and hepatocellular Carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 19: 788-799
33. Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest 2000; 80: 1399-1411
34. Su JJ, Qin GZ, Yan RQ, Huang DR, Yang C, Lotlikar PD. The expression of insulin-like growth factor II, hepatitis B virus X antigen and p21 in experimental hepatocarcinogenesis in tree shrews. Ann Acad Med Singapore 1999; 28: 62-66
35. Sohda T, Iwata K, Soejima H, Kamimura S, Shijo H, Yun K. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma. J Hum Genet 1998; 43: 49-53
36. Uchida K, Kondo M, Takeda S, Osada H, Takahashi T, Nakao A, Takahashi T. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinog 1997; 18: 193-198
37. Ooasa T, Karasaki H, Kanda H, Nomura K, Kitagawa T, Ogawa K. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines. Mol Carcinog 1998; 23: 248-253
38. Seo JH, Kim KW, Murakami S, Park BC. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma. J Korean Med Sci 1997; 12: 523-531
39. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564-568